In addition to this phenomenon found in depression, in Parkinson’s disease, we have found that neurotrophins are specific to the promotion of neurogenesis in the brain and could have potential in the treatment of Parkinson’s disease as a complement to cellular replacement therapies [112]. The gene discussed is BDNF; the disease is major depressive disorder.